As reports surfaced last week about McKesson considering the potential sale of its technology solutions unit, industry observers suggest that some factors might be aligning for the healthcare giant to reassess its stake in the healthcare IT business.
To a degree, such assessments are part of the normal course of business for companies in today’s financial world, says John Osberg, managing partner at Informed Partners, a consulting firm that offers strategic business development services for healthcare companies. It’s common for large companies to review their portfolios and make strategic decisions, he notes.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access